OVID THERAPEUTICS INC.
Last · NasdaqCM$2.41-0.05 (-2.03%)stale · yahoo · 57h ago
Market cap$470.67M195.3M sh
P/E · TTM-11.2fwd -6.4 · eps -0.22 · loss
Beta0.23vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.18$3.105
Volume876.0Ksession
Loading chart…
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.09
Est. revenue
31,090
Earnings transcripts
- Issuer webcast
Earnings call transcript
OVID THERAPEUTICS INC.
- Issuer webcast
Business and Pipeline Update Webcast
OVID THERAPEUTICS INC.
- Issuer webcast
Webcast
OVID THERAPEUTICS INC.
- Issuer webcast
Webcast
OVID THERAPEUTICS INC.
- Issuer webcast
Webcast
OVID THERAPEUTICS INC.
- Issuer webcast
Webcast
OVID THERAPEUTICS INC.
Press & signals
- GlobeNewswire
Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
- GlobeNewswire
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
Documents
FormReporting forFiledFlags